CVS Health Corp.’s stock rose 2.6% Monday after a report surfaced of a meeting between the health-care company and its major hedge-fund investor, Glenview Capital Management. CVS’s stock rose $1.65 to …
CVS’s stock rises nearly 3% on report of meeting with large hedge fund Glenview Capital
view original post